Halperin SA - Search Results

1

Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: results of a randomized, controlled comparison.

Scheifele DW, McNeil SA, Ward BJ, Dionne M, Cooper C, Coleman B, Loeb M, Rubinstein E, McElhaney J, Hatchette T, Li Y, Montomoli E, Schneeberg A, Bettinger JA, Halperin SA; PHAC /CIHR Influenza Research Network. Scheifele DW, et al. Among authors: halperin sa. Hum Vaccin Immunother. 2013 Nov;9(11):2460-73. doi: 10.4161/hv.25580. Epub 2013 Jul 9. Hum Vaccin Immunother. 2013. PMID: 23839537 Free PMC article. Clinical Trial.

2

Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children.

Halperin SA, Smith B, Mabrouk T, Germain M, Trépanier P, Hassell T, Treanor J, Gauthier R, Mills EL. Halperin SA, et al. Vaccine. 2002 Jan 15;20(7-8):1240-7. doi: 10.1016/s0264-410x(01)00428-5. Vaccine. 2002. PMID: 11803087 Clinical Trial.

3

The changing age and seasonal profile of pertussis in Canada.

Skowronski DM, De Serres G, MacDonald D, Wu W, Shaw C, Macnabb J, Champagne S, Patrick DM, Halperin SA. Skowronski DM, et al. Among authors: halperin sa. J Infect Dis. 2002 May 15;185(10):1448-53. doi: 10.1086/340280. Epub 2002 Apr 22. J Infect Dis. 2002. PMID: 11992280

4

Use of lidocaine-prilocaine patch to decrease intramuscular injection pain does not adversely affect the antibody response to diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate and hepatitis B vaccines in infants from birth to six months of age.

Halperin BA, Halperin SA, McGrath P, Smith B, Houston T. Halperin BA, et al. Among authors: halperin sa. Pediatr Infect Dis J. 2002 May;21(5):399-405. doi: 10.1097/00006454-200205000-00010. Pediatr Infect Dis J. 2002. PMID: 12150176 Clinical Trial.

5

Population-based epidemiology of invasive pneumococcal infection in children in nine urban centers in Canada, 1994 through 1998.

Bjornson GL, Scheifele DW, Halperin SA; Canadian Paediatric Society/Health Canada Immunization Monitoring Program, Active. Bjornson GL, et al. Among authors: halperin sa. Pediatr Infect Dis J. 2002 Oct;21(10):947-50. doi: 10.1097/00006454-200210000-00012. Pediatr Infect Dis J. 2002. PMID: 12394818

6

Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccine.

Halperin SA, Scheifele D, Mills E, Guasparini R, Humphreys G, Barreto L, Smith B. Halperin SA, et al. Vaccine. 2003 Jun 2;21(19-20):2298-306. doi: 10.1016/s0264-410x(03)00173-7. Vaccine. 2003. PMID: 12744860 Clinical Trial.

7

A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant.

Halperin SA, Van Nest G, Smith B, Abtahi S, Whiley H, Eiden JJ. Halperin SA, et al. Vaccine. 2003 Jun 2;21(19-20):2461-7. doi: 10.1016/s0264-410x(03)00045-8. Vaccine. 2003. PMID: 12744879 Clinical Trial.

8

Safety and immunoenhancing effect of a Chlorella-derived dietary supplement in healthy adults undergoing influenza vaccination: randomized, double-blind, placebo-controlled trial.

Halperin SA, Smith B, Nolan C, Shay J, Kralovec J. Halperin SA, et al. CMAJ. 2003 Jul 22;169(2):111-7. CMAJ. 2003. PMID: 12874157 Free PMC article. Clinical Trial.

9

Immunization Monitoring Program, Active: a model of active surveillance of vaccine safety.

Scheifele DW, Halperin SA; CPS/Health Canada, Immunization Monitoring Program, Active (IMPACT). Scheifele DW, et al. Among authors: halperin sa. Semin Pediatr Infect Dis. 2003 Jul;14(3):213-9. doi: 10.1016/s1045-1870(03)00036-0. Semin Pediatr Infect Dis. 2003. PMID: 12913834

10

A pilot study to quantify parental anxiety associated with enrollment of an infant or toddler in a phase III vaccine trial.

Langley JM, Halperin SA, Smith B. Langley JM, et al. Among authors: halperin sa. Vaccine. 2003 Sep 8;21(25-26):3863-6. doi: 10.1016/s0264-410x(03)00304-9. Vaccine. 2003. PMID: 12922120 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

375 results

Search Page